期刊名称：NEUROLOGY
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
As the leading clinical neurology journal worldwide, Neurology is directed to physicians concerned with diseases and conditions of the nervous system. The journal's purpose is to advance the field by presenting new basic and clinical research with emphasis on knowledge that will influence the way neurology is practiced. The journal is at the forefront in disseminating cutting-edge, peer-reviewed information to the neurology community worldwide. Editorial content includes full-length Articles, Brief Communications, Clinical/Scientific Notes, Views & Reviews (including Medical Hypothesis papers), Issues of Neurological Practice, Historical Neurology, NeuroImages, , Humanities, Correspondence, Book Reviews, Software Reviews, Calendar Listings, and position papers from the American Academy of Neurology. Content appearing solely online includes post publication peer review, selected NeuroImages, Neurology's Patient Page, and supplementary data (including video) for specific articles. The online version is considered the canonical version of the journal because it includes all content available to the reader.
Neurology is indexed in Index Medicus, EMBASE/Excerpta Medica, Biological Abstracts, Psychological Abstracts, and Current Contents (Life Sciences and Clinical Medicine).
Instructions to Authors
Neurology adheres to the guidelines set by the International Committee of Medical Journal Editors regarding authorship.1 Persons designated as authors must meet all of the following criteria: (1) contributing to the conception and design, or analyzing and interpreting data; (2) drafting the article or revising it critically for important intellectual content; and (3) approving the final version to be published. Supporting the study or collecting data does not constitute authorship. Authorship based solely on position (e.g., research supervisor, department head) is not permitted.
Multicenter trials attributed to corporate or multiple authors must list all authors in the authorship position below the title or in an Appendix. See the requirements for Group Authorship below.
Manuscripts submitted for publication as supplements must list all authors, including the person who drafted the original manuscript. If that person is omitted from the author list, the corresponding author must inform the Editor-in-Chief who the person is and why the individual was not listed as an author.2
Neurology complies with the position of the International Committee of Medical Journal Editors on "Conflict of Interest." Conflict of interest for authors is defined as "financial and other conflicts of interest that might bias their work."1
Completed Author Disclosure Forms are required for all manuscripts. Failure to reveal all pertinent information constitutes a fraudulent submission and may cause a published paper to be retracted and the authors to be prohibited from further submission to Neurology. A signed Copyright Transfer Agreement is also required upon submission. Indicate the manuscript number on all submitted forms.
Authors are also responsible for making certain that their final, accepted manuscript and page proofs provide full disclosure of all potential conflicts of interest (financial or nonfinancial) and any other pertinent financial information.2
Clear statements of industry-sponsored research and author participation in corporate activities are required for evaluation of a manuscript. Neurology now requires the principal author to declare in writing that he or she takes full responsibility for the data, the analyses and interpretation, and the conduct of the research; that he or she has full access to all of the data; and that he or she has the right to publish any and all data, separate and apart from the attitudes of the sponsor.3
Group Authorship
Group authorship includes those manuscripts authored by study groups where one or more co-authors are listed in an Appendix. Corresponding authors of these manuscripts must fill out a Group Authorship Disclosure Form and include it with the submission to Neurology.
The corresponding author is also responsible for obtaining the Journal's standard Author Disclosure form from all authors listed on the title page and appendix. These forms must be kept on file at the corresponding author's office and should not be submitted to Neurology.
Corresponding authors of group studies are also responsible for disclosing any co-author's potential or real, financial or nonfinancial conflicts of interest. These must be stated in the manuscript and in writing to the Editor-in-Chief of Neurology.
The corresponding author must keep Author Disclosure forms for five years from the date of original submission of the manuscript, and should be prepared to submit all individual authorship disclosure forms to the Editor-in-Chief if requested.
Duplicate Publication
Redundant or duplicate publication is publication of data, tables, figures, or any other content that substantially overlaps with previously published material. This includes work published by others or any author of the manuscript submitted to Neurology. When submitting a paper, the author should make a full statement to the Editor-in-Chief in the cover letter about all submissions and previous reports (in any language) that might be regarded as redundant or duplicate publication of the same or very similar work. The author should alert the Editor-in-Chief if the work includes subjects about which a previous report has been published. Any such work should be referred to and referenced in the new paper and a copy of the material should be included with the submission.1
Redundant or duplicate publication is considered fraudulent and will result in rejection of the paper (if detected prior to publication) and notification of authorities at the institution of the submitting author(s). Other sanctions may be made. If the Editor-in-Chief was not aware of the violations and the article has already been published, then a notice of redundant and duplicate publication will be published.
Clinical Trials and CONSORT
Authors reporting the results of randomized, controlled clinical trials must provide a CONSORT statement. This statement includes a checklist (for reviewers) and flow diagram (for publication) detailing the methods used by the authors.4
To view the models used for CONSORT, go to the CONSORT statement home page, www.consort-statement.org, for the current version. Click on "Statement." This will link you to the Checklist and Flowchart. The Flowchart should be Figure 1 of the submitted manuscript. When composing the flowchart for submission, please ensure that it is no wider than one journal column (approximately 31/2 in. or 8 cm.). Refer to the print journal for column width examples.
The checklist can be copied (cut and pasted) off this website into a Word Document for completion. The checklist can then be uploaded with the original submission under "Additional Data" or faxed to the editorial office (585) 271-2009.
Neurology will consider uncontrolled, nonrandomized, or unblinded clinical trials as Brief Communications or Clinical/Scientific Notes. These manuscripts do not require the CONSORT statement. For more information on reporting clinical trials, please refer to our editorial policy statement.5 When reporting experiments on human subjects, indicate whether the procedures were approved by the ethical standards committee on human experimentation (institutional or regional). Do not use patients' names, initials, or hospital numbers anywhere in the manuscript (including figures).1
Clear statements of industry-sponsored research and author participation in corporate activities are required for evaluation of a manuscript. We will now require the principal author to declare in writing that he or she will take full responsibility for the data, the analyses and interpretation, and the conduct of the research; that he or she had full access to all of the data; and that he or she had the right to publish any and all data, separate and apart from the attitudes of the sponsor.3
Genetic Association Studies
Authors of genetic association studies must consider whether their results are likely to be considered of sufficient power and interest to warrant publication. Neurology follows the guidelines outlined by authorities in the genetics research field.6
For standard pedigree symbols and nomenclature, please refer to the established guidelines.7 Authors should also follow the mutation nomenclature rules of the Human Genome Variation Society.8 In addition, authors reporting such sequence variants of a gene should submit it to the gene-specific mutation database before the manuscript is submitted to confirm its accuracy.
Ombudsman
For the benefit of authors, co-authors, editors, reviewers, and readers, Neurology has an Ombudsman. Appointed by the American Academy of Neurology Board of Directors, this person acts as a mediator between authors and the Editorial Office. The Ombudsman can investigate editorial process: delays in peer review, challenges to publication ethics, and cases of editorial bias. The Ombudsman will not handle complaints about the substance (rather than process) of editorial decisions, criticisms regarding editorial content, or accusations of scientific misconduct.9
The author must first make the complaint to the Editorial Office in writing (to e-mail, click here [neuro_journal@urmc.rochester.edu] or address to: neuro_journal@urmc.rochester.edu). If the author feels the matter is not appropriately handled, she/he can appeal directly to the Ombudsman: Jack P. Whisnant, MD, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, fax (507) 284-1516, e-mail: whisnant@mayo.edu.
GENERAL INFORMATIONJournal Addresses
Manuscript submissions, editorial inquiries, and information for the Newsletter and Calendar should be sent to the Editor-in-Chief:
Robert C. Griggs, M.D.
Editor-in-Chief, Neurology
1351 Mt. Hope Avenue, Suite 203
Rochester, NY 14620
Tel: (585) 275-0816
Fax: (585) 271-2009
E-mail: neuro_journal@urmc.rochester.edu
Effective
February 2003, new submissions should be submitted electronically using our online manuscript submission and tracking system (see instructions under Manuscript Submission).
Address noneditorial and business correspondence to:
Publisher, Neurology
Lippincott Williams & Wilkins
351 West Camden Street
Baltimore, MD 21201
Fax (410) 410-528-1487
E-mail: sjharris@lww.com
Send requests for permission/copyright release to:
Rights Department
Lippincott Williams & Wilkins
351 West Camden Street
Baltimore, MD 21201
Attn.: Neurology
or fax (410) 528-8550
or email: journalpermissions@lww.com
Classification of Manuscripts
Neurology publishes full-length Articles, Brief Communications, Clinical/Scientific Notes, Views & Reviews (including Medical Hypothesis papers), Issues of Neurologic Practice, Historical Neurology, Nisus: Neurology and the Humanities, NeuroImages, Video NeuroImages, and Correspondence. In the covering letter, the corresponding author should specify the type of paper being submitted. Details regarding these journal departments are described below.
Articles are full-length reports of original research. They require a structured abstract. In general, references should not exceed 40-45. Multiple citations for a single point are usually duplicative; authors should cite the best references.
Brief Communications are short reports of original research. They contain no more than 1,250 words, excluding references, and have an abstract no longer than six lines (approximately 70 words), a total of up to three tables or figures, and no more than 10 references.
Clinical/Scientific Notes are abbreviated reports on cases or preliminary studies. They contain no more than 750 words, excluding references, have no abstract, no more than one table or figure, and no more than seven references.
Views & Reviews are either review articles or opinion statements that provide a summary of the most important recent information on a topic. In general, they should not exceed 2,500 words, excluding references. References should cite the most important papers in the field (generally not more than 60). Neurology welcomes inquiries on Views & Reviews content or format and will consider manuscripts proposing a Hypothesis only if written by an acknowledged contributor to the field.
Issues of Neurologic Practice are articles related to the contemporary practice of Neurology in the United States.
Historical Neurology articles present original research on historical aspects of Neurology: neurologists, diagnostic methods, or particular events that have shaped the field. In general, they should be a maximum of 2500 words. They should have an abstract (a structured abstract is optional).
Nisus: Neurology and the Humanities submissions may be in the form of poetry or prose. The manuscript must be 2500 words or less. Nisus is intended to link Neurology with the humanities through poetry and through fiction and creative nonfiction that make use of imagery, scenes, and dialogue. The author must label a prose submission as "Fiction," "Essay," "Personal History," or "Memoir." For a discussion of material suitable for Nisus, please see the Editorial "Nisus Steps Forth."10 Some submissions to Nisus may also be eligible for the annual AAN Creative Expression of Human Values in Neurology Award. Consult the Awards section of the AAN website for details.
NeuroImages are interesting, previously unpublished photomicrographs, patient photographs, neuroradiologic images, or other pictorial material. They should consist of no more than two separate figures and have a title of less than 40 characters (including spaces and punctuation), a legend of 50 words or less, a case summary of 100 words or less, and up to two references. Authors submitting in this category do so with the understanding that, if accepted, their NeuroImage might appear only in the online journal.
Video NeuroImages have the same requirements as NeuroImages except are accompanied by a video. Authors should submit Video NeuroImages according to the requirements listed in Video Submissions. These submissions should portray activity (e.g., seizure activity, movement disorders, tics). A static portion of the video should also accompany the submission and will be published in print if it is accepted. Print readers will be alerted that the online version contains the full-length video.
Correspondence is restricted to comments about studies published in Neurology within the last six months. Neurology does not consider letters pertaining to published correspondence. Letters should be a maximum of 400 words with no more than five references. They will be published at the discretion of the Editor-in-Chief. Readers wishing to submit Correspondence should access the online version of the article at www.neurology.org and click on "Submit a response to this article" in the box at the opening page. Accepted comments will usually be posted within 10-14 days of acceptance. Correspondence may be edited for content and clarity. Posted comments will be considered for subsequent print publication in the Correspondence section of Neurology. Note that if Correspondence is chosen for subsequent print publication, the letter writer will not see page proofs. Please ensure the accuracy of the submitted Correspondence. To submit comments, you must be a member of the American Academy of Neurology or have a current subscription to Neurology. Correspondence cannot be uploaded through our online submission system.
Expedited Publication
Neurology will accept a limited number of submissions for expedited publication.11 In addition to Articles, Brief Communications and Clinical/Scientific Notes of exceptional interest can also be expedited. Expedited manuscripts that are accepted will usually be published within 10-14 weeks from the date of receipt by Neurology. Submissions must meet strict length limitations. Expedited articles must not exceed four published pages (3,000 words), including letters and spaces, figures, tables, and references. Authors should refer to published journal issues to estimate the space equivalence of tables and figures.
Authors should be selective in requesting expedited publication. Papers accepted for this section must be both high priority and timely. Manuscripts requiring major revision will not be expedited.
Manuscripts not accepted for expedited publication will be rejected and will not be considered for routine publication.
Author Request for Reviewers
Authors may suggest up to five appropriate reviewers for their work. Authors must provide full contact information (institution, mailing address, phone number, fax number, and e-mail address) for each of the chosen reviewers. Authors may exclude up to two reviewers whom they feel may be competitors or have a conflict of interest.
Peer Review and Manuscript Timeline
Neurology accepts approximately 20% of submitted manuscripts. Accepted papers reveal novel findings with broad clinical applicability. Two or more leading experts in the field review most papers. The following is a general timeline for the average submitted manuscript.
Initial submission - Author should receive:
- Acknowledgment of manuscript receipt within 2 days
- Initial review decision within 6 weeks of the acknowledgment notice (unless an adjudication or additional opinion is needed). If difficulties with the review process delay a decision, Neurology will usually provide notification to authors.
Revised submission (if the Editor-in-Chief requests revision) - Author should receive:
- Acknowledgment of revision receipt within 2 days
- Second review decision within 6 weeks of the acknowledgment notice
If accepted - Author should receive:
- Page proofs within 6-8 weeks of notification of acceptance
- Manuscripts will generally be published 3-6 months from notification of acceptance.
Authors can check the status of their manuscript by accessing their password-protected manuscript file at the Bench>Press site (see below). Or, please contact the Editorial Office at (585) 275-0816 or by e-mail (click here or address to: neuro_journal@urmc.rochester.edu).
Page Proofs and Reprints
The Publisher will send electronic proofs to the corresponding author for correction. Please check them carefully--it is the author's responsibility to ensure that there are no errors in the proofs. Changes done in the course of copyediting to conform to Journal style should be allowed to stand if they do not alter meaning. All changes should be clearly marked and the proofs returned promptly to the Publisher, Lippincott Williams & Wilkins, 351 West Camden Street, Baltimore, MD 21201; fax 410-361-8040.
Authors will receive a reprint order form and a price list with the page proofs. Reprint requests should be faxed to the publisher at (215) 521-8485. Reprints are normally shipped 6 to 8 weeks after publication of the issue in which the item appears. Contact the Reprints Department with any questions.
MANUSCRIPT PREPARATIONSubmissions to Neurology should be prepared electronically and submitted in a standard word processing format; Microsoft Word (or Corel WordPerfect) is preferred. Although conversions can be made from other word processing formats and PDF files, the vagaries of the conversion process may introduce errors. Do not submit ASCII text files.
E-mail attachments can be corrupted in transit and are not an acceptable form of submission.
For a detailed list of supported electronic file formats and instructions for citing online content, click here.
Journal Style
Authors should refer to the "Uniform requirements for manuscripts submitted to biomedical journals"1 and Neurology's "Suggestions to authors"11 for style and publication guidelines.
Neurology adheres to the recommendations of the International Committee of Medical Journal Editors concerning the order of authors and protection of patient anonymity.1 Do not use patients' names, initials, or hospital numbers anywhere in the manuscript (including figures).
Arabic numerals should be used for numbers above nine, for designators (e.g., case 5, day 2, etc.), and for units of measure, including time. Numbers should be spelled out if below 10 (including ordinals), at the beginning and end of sentences, and for fractions less than one. Widely accepted abbreviations may be used throughout the manuscript without definition (click abbreviations for list). Generic drug names should generally be used. When proprietary brands are used in research, include the brand name in parentheses in the Methods section.
MANUSCRIPT REQUIREMENTSForms Required for Submission
Author Disclosure - every author, applicable for all submissions
Group Authorship Disclosure - applicable only for study groups and other types of multiple authorship
CONSORT statement - applicable only for clinical trials
Copyright Transfer Agreement - applicable for all submissions, only corresponding author must sign.
Please indicate the assigned manuscript number on all submitted forms. This number is provided to the corresponding author in the e-mail verification of a successfully uploaded manuscript.
Journal Style
Suggestions to Authors - Neurology's preferences for writing style
Accepted Abbreviations - Widely accepted abbreviations should be spelled out at first mention in the text with the abbreviation in parentheses then they may be used throughout the remainder of the manuscript without definition.
Naming Standards for Online-Only Content Index Medicus journal abbreviations
Supported Electronic Formats - authors who use other formats may be required to resubmit their material
Authors should refer to the "Uniform requirements for manuscripts submitted to biomedical journals"1 and Neurology's "Suggestions to Authors"12 for style and publication guidelines.
Neurology adheres to the recommendations of the International Committee of Medical Journal Editors concerning the order of authors and protection of patient anonymity.1 Do not use patients' names, initials, or hospital numbers anywhere in the manuscript (including figures).
Arabic numerals should be used for numbers above nine, for designators (e.g., case 5, day 2, etc.), and for units of measure, including time. Numbers should be spelled out if below 10 (including ordinals), at the beginning and end of sentences, and for fractions less than one. Generic drug names should generally be used. When proprietary brands are used in research, include the brand name in parentheses in the Methods section.
Manuscript Preparation
Submissions to Neurology should be prepared electronically and submitted in a standard word processing format; Microsoft Word (or Corel WordPerfect) is preferred. Although conversions can be made from other word processing formats and PDF files, the vagaries of the conversion process may introduce errors. Do not submit ASCII text files.
For a detailed list of supported electronic file formats and instructions for citing online content, click here.
The manuscript should be formatted so as to print out double-spaced at standard 8? x 11" or A4 (international) paper dimensions, using a 12 pt. font size and a default typeface (e.g., Helvetica, Times New Roman). Set the left margin at one inch, and the right margin at one-half inch or more. Do not justify the right margin; leave it unaligned.
Place the page number and lead author's last name in the upper right corner of each page (including the reference pages, tables, and figure legends). Provide a word count for the paper and abstract, and a character count for the title (including spaces and punctuation).
Observe the following guidelines in preparing your electronic manuscript file:
- Use hard returns only at the end of paragraphs and display lines (e.g., titles, subheadings)
- Do not insert a tab, indent, or extra spaces before the beginning of a paragraph or for list entries
- Do not indent run-over lines in references
- Set line spacing at 2 (not 1.5 or 2.5)
- Turn off automatic hyphenation and justification
- Do not use automatic references
- Do not insert hard page breaks
- Take care to enter "one" (1) and lowercase "el" (l), as well as "zero" (0) and capital "oh" (O), correctly
Key dashes as follows: Use a single hyphen with space before it for a minus sign, and a double hyphen (with space before and after) to indicate an em-dash (long dash) in text. Use only single hyphens in the references.
Nonstandard characters (Greek letters, mathematical symbols, etc.) should be coded consistently throughout the text. Please make a list of such characters and provide a key to the codes used.
Cover Letter
The cover letter for the new submission should include the following: Manuscript title Manuscript classification List of all contents included in the submission Indication of willingness to pay for color illustrations (if applicable) Disclosures of financial interest, or notification of redundant or duplicate publication to Editor-in-Chief (if applicable) Author's statement of responsibility for clinical trial data (if applicable)
Title Page
The title should be no more than 96 characters in length, including spaces, punctuation, and subtitle. Titles should be interesting and informative. They may include widely accepted abbreviations (click here for a complete list).
The title page should include the names of the authors followed by their highest academic degrees (MD, PhD) and their institutional affiliations. Authors may use either full names or initials except when there are more than four; in that case, use only initials. Include the name, address, telephone number, fax number, and e-mail address of the author who will be receiving correspondence and proofs.
List disclosures on the title page, including any financial support from, or equity positions in, manufacturers of drugs or products mentioned in the manuscript.
If applicable, the title page should indicate "Supplementary Content" below the authors' affiliations.
Abstract
Full-length Articles require structured abstracts that should not exceed 250 words (one double-spaced typed manuscript page). A structured abstract should be organized by: objective (or background), methods, results, and conclusions. For Views & Reviews, provide a 150- to 200-word abstract, structured if possible. Brief Communications require an unstructured abstract no longer than six typewritten lines (approximately 70 words). Clinical/Scientific Notes should not have an abstract.
Figures
Authors should examine a recent issue of Neurology to plan the appropriate layout and size when preparing their figures. The width of a photograph should not be less than 8 cm (3.5 inches or 20.5 picas). Symbols, lettering, and numbering should be sufficiently large to remain legible after a figure has been reduced to fit the width of a single column (i.e., they should measure at least 2 mm in the reduced figure).
Multipart figures should be labeled with capital roman letters, A, B, C, etc.
Internal scale markers must appear on microscopic photographs.
In graphs, standard symbols should be used for data points in the following order:  Symbols like the following are not acceptable:  To prevent wasted space, axes should end no more than one increment beyond the final data points. Explanatory lettering should not extend beyond the ends of the axes.
A signed patient consent form must accompany photographs of recognizable patients.
Figures should not include titles, abbreviation keys, or patient initials. Titles and abbreviations should be placed in the figure legend, not on the figure itself. Avoid patient initials and other identifying elements.
Figure legends should be double-spaced and appear on a separate page of the manuscript document file. Number figures in the order of their mention in the text.
Digital figures
For maximum quality, figures should be developed as separate files in an approved format and should not be embedded in the text document. Upload each figure as a separate image file. JPG and GIF files may be submitted through the Bench>Press system for review purposes only. If the manuscript is accepted for publication, TIFF or EPS files may be required to be submitted by the author. (Click here for detailed information on digital figure submission.)
Authors who are unable to provide figures in an approved electronic format must follow the guidelines below:
- To assure optimal detail and contrast, figures must be first-generation glossy prints, laser prints, or original artwork. Glossy prints should be unmounted and should be no larger than 20 x 25 cm (8" x 10"). Indicate cropping, if needed, on an accompanying photocopy, not on the original photograph. If the figure is a composite of many separate images, provide a photocopy of the montage to assist the editors and reviewers.
- On the back of each figure, indicate the name of the lead author, the figure number, and the top of the figure.
- Provide one set of reproduction-quality figures in an envelope clipped to the back of the manuscript. Retain a set of publication-quality figures or negatives until the manuscript is published. Figures will not be returned.
Please note that hard copies of figures may be requested for the review process or if the paper is accepted for publication.
Color Illustrations
Color illustrations are often helpful in demonstrating findings and illustrating concepts. However, they are expensive. The author will be charged $1200 for a single color figure and $1600 for multiple color figures on the same page. If color images span more than one printed page, the author will be charged an additional $1200 (for one image) or $1600 (for multiple images) per page. For online-only color images, authors will be charged $600 for one page of color and $100 for each additional page of color. Please refer to the instructions regarding figures above. For supported electronic file requirements and formats click here.
Tables
Submit tables as part of the manuscript document file. Authors should consult a recent issue of Neurology before designing tables. Tables should be brief and easily understood without referring to the text. Extensive tabular data may be posted on Neurology's web site when the article is published (see Supplementary Content below).
Type each table, with a title, on a separate page. All tables must be double-spaced. Number tables in the order of their mention in the text.
Supplementary Content
Tables and other illustrative material submitted to Neurology should be succinct and easily interpreted by the general readership. Often there are lengthy data that are important to the study, yet difficult to summarize in print. These data, which may take the form of tables, figures, data, references, or appendices, can be posted on the Neurology web site and can also be referenced in the print journal.
Authors who wish to submit detailed data to be considered with their manuscript should upload this data upon submission or, if submitting conventionally, provide the data on a separate diskette or CD-ROM labeled "web site only." The online data should also be referenced within the text, and the title page of the paper should indicate "Supplementary Content" below the authors' affiliations. If the manuscript is accepted, this web site data will be posted as submitted and will not be professionally copyedited or proofread. For this reason, authors should carefully review their material. Neurology will not be responsible for errors or omissions. Click here for details on supported formats and citation and labeling instructions. See Supplemental/Additional Data for upload information.
Video Submissions
Submit videos as separate supplemental files with your original manuscript submission. A brief description of each video should appear after the references, titled "Video legends." A textual legend to appear with the video should also be supplied.
Videos should be named in the order of their text citation (e.g., video1.mov). If a video is directly related to a figure or table, name it accordingly (e.g., Fig4video3.mov). Avoid lengthy file names.
A signed patient consent form must accompany any video that presents images of recognizable patients.
Accepted Formats
Supported video formats include mpeg, avi, mov, and wav. Videos must be prepared as QuickTime files no larger than 10 MB. We recommend Sorenson or Cinepak compression, though other codecs may be used. Color depth should be kept to a minimum, using grayscale for black and white videos. Frame size should be limited to 450 x 375 pixels for best viewing within a browser on most monitors.
Reference Style
Cite references in numerical order in the text. List all authors when there are six or fewer; for seven or more, list only the first three and add "et al." Use Index Medicus abbreviations for journal names but eliminate U.S. cities cited in parentheses after the name of a journal. Do not reference papers that are "submitted"; these can be mentioned in the body of the text. Authors must provide "submitted" and "in press" manuscripts clearly labeled as such by uploading them with submission or faxing them to the editorial office. Personal communications should also be mentioned in the body of the text.
References should follow the Vancouver style described in the "Uniform requirements for manuscripts submitted to biomedical journals" with the exception that pagination should be complete.1 The following are sample styles:
Journal article
Krupp LB, Elkins LE. Fatigue and declines in cognitive functioning in multiple sclerosis. Neurology 2000;55:934-939.
Book
Rowland LP, ed. Merritt's Neurology, 10th ed. Philadelphia: Lippincott Williams & Wilkins, 2000.
Book chapter
Kinsbourne M, Graf WD. Disorders of mental development. In: Menkes JH, Sarnat HB, eds. Child Neurology, 6th ed. Philadelphia: Lippincott Williams & Wilkins, 2000:1155-1211.
Published abstract
van den Bent MJ, Keime-Guibert F, Brandes AA, Taphoorn MJB, Eskens FALM, Delattre J-Y. Temozolomide chemotherapy in recurrent oligodendroglioma. Neurology 2000;54 (suppl 3):A12. Abstract.
Unpublished material
Mark MH, Dickson DW, Schwarz KO, et al. Familial diffuse Lewy body disease. Presented at the 10th International Symposium on Parkinson's Disease; October 19, 1991; Tokyo.
Letter
Neurology Assessment Panel. Assessment of neuropsychological testing. Neurology 1997;49:1183-1185. Letter.
Online book or web site
Garrow A, Weinhouse G. Anoxic brain injury: assessment and prognosis. In: UpToDate Cardiovascular Medicine [online]. Available at: www.UpToDateInc.com/card. Accessed February 22, 2000.
Online journal article
Miyamoto O, Auer RN. Hypoxia, hyperoxia, ischemia, and brain necrosis. Neurology [serial online] 2000;54:362-371. Available at: www.neurology.org. Accessed February 23, 2000.
Monograph in electronic format
Chee M, Chiappa K. Waveguide: an EEG atlas on CD-ROM. Philadelphia: Lippincott Williams & Wilkins, 1998.
Computer file
EMG analyzer software [computer program]. Version 1.0. Tustin, CA: B & L Engineering, 1998.
Post-Publication Peer Review (online only)
Henderson VW, Drachman DA. Dementia and voter competence [electronic response to Swerdloff, Post-election anecdote]. Neurology 2002. http://www.neurology.org/cgi/eletters/58/7/995 (accessed 21 May 2002).
MANUSCRIPT SUBMISSIONEffective February 2003, new manuscripts should be submitted electronically using Bench>Press, Neurology's online manuscript submission and tracking system from HighWire Press. Authors who use Bench>Press will be able to monitor the status of their submissions online by accessing their password-protected manuscript file at the Bench>Press site. Go to http://submit.neurology.org to upload a new manuscript.
Online Submission
Authors are not required to be members of the American Academy of Neurology or subscribers to Neurology to use Bench>Press.
Users must register when accessing the Bench>Press system for the first time. A password will be created which applies to all journals using the system. Once you have registered for your first Bench>Press journal, you do not need to re-register in order to use another journal's system. Simply log in with your existing email address and password.
Registering with Bench>Press
To set up your personal Bench>Press access, click on "Create a new account." You will be asked to complete three steps:
1. Email/Password
Enter your email address. This is your unique user identification and will be needed to log onto the system on all occasions (as a reviewer or author).
Enter a password. This will be encrypted for security reasons, and will not be known to Neurology or Bench>Press staff. If you forget your password, you will need to click on "I have forgotten my password" and follow the steps outlined. Choose a "password hint" question and provide an answer. You will need to provide this answer if you forget your password.
2. Verification
A verification e-mail containing a URL will be emailed to you at the address you used to register. When you click it, you will need to click on the URL provided in the e-mail or copy and paste it into the address field in your web browser. This will verify your e-mail address and helps to ensure that your e-mail address is not being used fraudulently.
3. Profile
Once you have verified your e-mail address, you will be asked to provide a basic profile consisting of your contact information plus expertise terms. Although you may use the same e-mail address and password to access any journal using the Bench>Press system, you must create an individual profile with each journal.
Online Help and Feedback
Detailed HELP files are available throughout Bench>Press and can be used without stopping the submission process. If you experience problems, you may contact the Editorial Office at neuro_journal@urmc.rochester.edu.
Users are also encouraged to give us feedback on the system. A Feedback link appears on the navigation bar throughout the Bench>Press web site: Neurology-BP-feedback@highwire.stanford.edu.
Uploading a Manuscript
To begin uploading a submission, click here. At the Bench>Press home page, enter the author area and click on the "Submit a new manuscript" hyperlink. You will be presented with a series of fields for entering your manuscript information and uploading your text, table, figure, and video files. Supplemental data can also be uploaded (see Supplemental/Additional data for further information).
The system will automatically convert your files to a single PDF for reviewing purposes. You will be asked to approve the conversion before your manuscript is considered formally submitted to the journal. The conversion process can take up to 30 minutes. An e-mail will be sent informing you when the conversion is complete. Click on "Ready for you to proof" in the Author area to approve your article. During conversion, the system will automatically hyperlink the references to Medline (or, if the online journal is hosted by HighWire, the journal in which the article was published). Be sure to include the heading "References" at the top of the citations and follow Neurology's Reference Style for optimum linkage.
You may begin a submission and continue the process later by clicking on "Save/Continue" at the bottom of the screen when entering your manuscript information. This enables you to save that page or continue to the next page. If you choose not to complete the submission at that time, your manuscript will appear in the "Submissions in progress" queue in the Author area. If you decide not to complete the submission at all, you should choose "Withdraw." Do not submit the same paper more than once.
Please note:
-Do not include the cover letter in the body of the manuscript. It should be copied/pasted into the designated field.
-Copy and paste the abstract into the designated field. The abstract should, in addition, be part of the manuscript file.
-If your paper does not require an abstract, type "None".
Supplemental/Additional Data - Supplemental data is content that the author wishes to make available online if the article is accepted for publication. This material may include tables, figures, appendices, and video, and should be clearly marked as "Online Supplemental Data" at the top of each page. Additional data is material not intended for publication that the Editor-in-Chief and Editorial Office require for the peer-review process. This includes Author Disclosure forms, patient consent forms, in-press articles, and CONSORT checklists. Alternatively, these items can be faxed to the Editorial Office at: (585) 271-2009.
Detailed HELP files are available on Bench>Press throughout the submission process.
Author Disclosure and Copyright Forms
Signed Author Disclosure Forms and a signed Copyright Transfer Agreement must be on file at the Neurology Editorial Office before a final decision is made on a manuscript. Authors will be alerted if their file is incomplete. Please indicate the manuscript number on all submitted forms. This number is provided to the corresponding author in the e-mail verification of a successfully uploaded manuscript.
Manuscript Status
Authors who submit online through Bench>Press can keep track of the status of their manuscript throughout the peer-review process. Enter the Author area and click on "Manuscripts under review/check status."
Submitting a Revision
NOTE: If your original manuscript was not submitted through Bench>Press, you cannot submit your revision via Bench>Press. Your manuscript will still be administered through our prior manuscript tracking system until the final disposition is made. Please send your diskette and five paper copies of the revision to the Editorial Office.
To submit a revised manuscript via Bench>Press, enter the Author Area and click on "Submit a revised manuscript." You will be presented with your original manuscript information, which can be edited as necessary. You will then be required to upload your revised manuscript files (see "Submitting a Manuscript" for further details). Please include your response to the reviewers' comments and a cover letter to the Editor-in-Chief.
Invited Submissions
An invitation to write an Editorial or Commentary for the journal will also be requested via the Bench>Press system. Enter the Author Area and click on "Invited papers." You can accept or decline the invitation online. When submitting your commissioned article, click on "Invited papers to be submitted." The procedure for submission is the same as an unsolicited article (see Submitting a Manuscript).
Correspondence
Correspondence cannot be submitted through Bench>Press. See Correspondence for format and submission requirements.
After Acceptance
When a manuscript is accepted for publication the author may be requested to supply specific additional information and higher quality electronic replacement files for print. For more detailed information regarding electronic file requirements please see the "Manuscript Preparation" section of the Neurology Instructions for Authors or click here.
REFERENCES
- International Committee of Medical Journal Editors. Uniform requirements for manuscripts submitted to biomedical journals. Ann Intern Med 1997;126:36-47.
- Kieburtz K. Avoiding conflict of interest: responsibilities of authors, reviewers, and editors. Neurology 1998;51:1527-1528.
- Rosenberg RN, Aminoff M, Boller F, et al. Reporting clinical trials: Full access to all the data. Neurology 2002;58:347-348.
- Moher D, Schulz K, Altman D, for the CONSORT group. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. Lancet 2001;357:1191-1994.
- Kieburtz K. Policies on reporting clinical trials and publishing supplements. Neurology 1997;49:2-3.
- Bird TD, Jarvik GP, Wood NW. Genetic association studies: genes in search of diseases. Neurology 2001;57:1153-1154.
- Bennett RL, Steinhaus KA, Uhrich SH, et al. Recommendations for standardized human pedigree nomenclature. Am J Hum Genet 1995; 56:745-752.
- Dunnen JT, Antonarakis SE: Mutation nomenclature extensions and suggestions to describe complex mutations: a discussion. Hum Mutat 15:7-12, 2000.
- Griggs RC. Neurology: Ready for the new millennium. Neurology 2000;54:2.
- Goldblatt D. Nisus steps forth. Neurology 2001;57:381-382.
- Griggs R. Editorial message: From the new Editor-in-Chief. Neurology 1997;48:1.
- Daroff R, Rossi A, Stevens-Ross LM, et al. Suggestions to authors. Neurology 1996;46:298-300.
FURTHER INFORMATION
If you have questions, you may contact the Editor-in-Chief by e-mail (click here or address to: neuro_journal@urmc.rochester.edu).
Editorial Board
Editor-in-Chief
Robert C. Griggs, MD
Rochester, NY
e-mail: Neuro_Journal@urmc.rochester.edu
| Associate Editors |
Robert A. Gross, MD, PhD
Rochester, NY |
|
Michael P. McDermott, PhD
Rochester, NY |
|
Jonathan W. Mink, MD, PhD
Rochester, NY |
|
Steven R. Schwid, MD
Rochester, NY |
|
Continuing Medical Education
J. Clay Goodman, MD
Houston, TX
|
| Editor-in-Chief's Office |
Sharon L. Quimby
Senior Manuscript Editor |
|
Sandra A. Moriarity
Manager, Editorial Office |
|
Kathleen M. Pieper
Managing Editor
Neurology Online |
Patricia J. Goodman
Production Assistant |
|
Erin Tubbs
Editorial Assistant |
|
Morgan S. Serry
Editorial Associate |
Newsletter Editors Antonio Culebras, MD Robert J. Joynt, MD, PhD
Book Review Editor
Irene H. Richard, MD
Humanities Editor
David Goldblatt, MD
Patient Page Editors
Robin L. Brey, MD
Janet L. Jankowiak, MD
Ombudsman
Jack P. Whisnant, MD
Executive Office, American Academy of Neurology Catherine M. Rydell Executive Director 1080 Montreal Avenue St. Paul, MN 55116 Tel: (651) 695-1940 http://www.aan.com
Past Editors-in-Chief
Russell N. DeJong, MD (1907-1990)
(Founding Editor-in-Chief; 1951-1976)
Lewis P. Rowland, MD
(Editor-in-Chief 1977-1986)
Robert B. Daroff, MD
(Editor-in-Chief 1987-1996)
|
Academy Officers
Sandra F. Olson, MD
President
Thomas R. Swift, MD
President-Elect
Mark Hallett, MD
Vice-President
Timothy A. Pedley, MD
Secretary
Michael L. Goldstein, MD
Treasurer
|
| EDITORIAL BOARD |
Roger L. Albin, MD
Ann Arbor, MI |
Tetsuo Ashizawa, MD
Galveston, TX |
Richard J. Barohn, MD
Kansas City, KS |
David A. Bennett, MD
Chicago, IL |
Joseph Berger, MD
Lexington, KY |
Samuel F. Berkovic, MD
Victoria, Australia |
Thomas Bird, MD
Seattle, WA |
Julien Bogousslavsky, MD
Lausanne, Switzerland |
John C.M. Brust, MD
New York, NY |
David W. Chadwick, MD
Liverpool, UK |
Anne Cross, MD
St. Louis, MO |
Lisa DeAngelis, MD
New York, NY |
Thomas Feasby, MD
Edmonton, Alberta, Canada |
Allessandro Filla, MD
Naples, Italy |
Steven Galetta, MD
Philadelphia, PA |
Larry B. Goldstein, MD
Durham, NC |
J. Timothy Greenamyre, MD, PhD
Atlanta, GA |
Robert I. Grossman, MD
New York, NY |
George Karpati, MD
Montreal, Quebec, Canada |
David Knopman, MD
Rochester, MN |
Richard Lipton, MD
New York, NY |
W.T. Longstreth, Jr., MD
Seattle, WA |
Karen Marder, MD, MPH
New York, NY |
Mitchell B. Max, MD
Bethesda, MD |
Robert McKinstry, MD, PhD
St. Louis, MO |
Kimford J. Meador, MD
Washington, DC |
Hiroshi Mitsumoto, MD, DSc
New York, NY |
John Noseworthy, MD
Rochester, MN |
Olivier Rascol, MD, PhD
Toulouse, France |
Marc Patterson, MD
New York, NY |
Alan K. Percy, MD
Birmingham, AL |
William J. Powers, MD
St. Louis, MO |
Karen L. Roos, MD
Indianapolis, IN |
David A. Rottenberg, MD
Minneapolis, MN |
David B. Rye, MD, PhD
Atlanta, GA |
Roger Simon, MD
Portland, OR |
Harvey S. Singer, MD
Baltimore, MD |
Susan S. Spencer, MD
New Haven, CT |
William Theodore, MD
Bethesda, MD |
Kenneth L. Tyler, MD
Denver, CO |
Justin A. Zivin, MD, PhD
La Jolla, CA |
|
刊名字顺( Alphabetical List of Journals):
返回页首 